文献速递头颈部肿瘤放疗放疗物理与技术

头颈部放疗期间系列CBCT测量的腮腺影像生物标志物早期变化可预测慢性口干症

Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-07-10

这项回顾性分析对119例头颈部放疗患者(60或70 Gy,每次2 Gy,共6或7周)的每日kV CBCT图像进行腮腺变形配准勾画,计算腮腺平均CT值强度和体积的每周变化。结果显示,含CBCT变化特征的模型对≥1级口干症预测AUC为0.719,剂量/临床模型为0.709;对≥2级口干症,加入对侧腮腺变化后AUC从0.692提高至0.776。作者认为CBCT测量的腮腺影像特征变化率可改善慢性口干症预测。

要点

  • 所有患者治疗结束时腮腺体积均缩小,同侧平均缩小19.6%,对侧平均缩小17.7%。
  • ≥1级和≥2级口干症发生率分别为65%和16%。
  • 含CBCT变化特征的模型对≥1级口干症预测AUC为0.719,剂量/临床模型为0.709。

核心结论

  • CBCT测量的腮腺影像特征变化率在慢性口干症预测上优于仅用剂量信息。
  • 分析治疗定位时获取的CBCT图像可能提供一种低成本监测系统,以支持减少毒性的自适应放疗。

研究设计与样本

  • 回顾性分析纳入119例头颈部放疗患者,放疗方案为60或70 Gy,每次2 Gy,共6或7周。
  • 使用变形图像配准在每日kV CBCT图像上勾画腮腺,并用Dice相似系数和平均一致距离对照手动勾画轮廓量化配准精度。
  • 计算每个腮腺相对于第1周的平均每周CBCT测量的平均CT值强度和体积变化,并从每份计划提取剂量-体积直方图统计。
  • 采用单变量分析和惩罚逻辑回归分析与放疗后1年观察者评定口干症的关联。
  • 使用受试者工作特征曲线下面积(AUC)比较含CBCT变化影像特征的模型与仅含临床和剂量-体积直方图的模型对≥1级和≥2级口干症的预测。

主要发现

  • 所有患者治疗结束时腮腺体积均缩小,同侧腮腺平均缩小19.6%(范围0.9%-58.4%),对侧腮腺平均缩小17.7%(范围4.4%-56.3%)。
  • 治疗中体积变化与腮腺平均剂量高度相关(r = -0.318,P < 1e-6)。
  • ≥1级和≥2级口干症发生率分别为65%和16%。
  • 对≥1级口干症预测,变化影像模型AUC为0.719(95%CI 0.603-0.830),剂量/临床模型AUC为0.709(95%CI 0.603-0.815)。
  • 对≥2级口干症预测,剂量/临床模型AUC为0.692(95%CI 0.615-0.770),加入对侧腮腺变化后预测性能适度改善,AUC为0.776(95%CI 0.643-0.912)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether serial cone beam computed tomography (CBCT) images taken during head and neck radiation therapy (HNR) can improve chronic xerostomia prediction. METHODS AND MATERIALS: In a retrospective analysis, parotid glands (PGs) were delineated on daily kV CBCT images using deformable image registration for 119 HNR patients (60 or 70 Gy in 2 Gy fractions over 6 or 7 weeks). Deformable image registration accuracy for a subset of deformed contours was quantified using the Dice similarity coefficient and mean distance to agreement in comparison with manually drawn contours. Average weekly changes in CBCT-measured mean Hounsfield unit intensity and volume were calculated for each PG relative to week 1. Dose-volume histogram statistics were extracted from each plan, and interactions among dose, volume, and intensity were investigated. Univariable analysis and penalized logistic regression were used to analyze association with observer-rated xerostomia at 1 year after HNR. Models including CBCT delta imaging features were compared with clinical and dose-volume histogram-only models using area under the receiver operating characteristic curve (AUC) for grade ≥1 and grade ≥2 xerostomia prediction. RESULTS: All patients experienced end-treatment PG volume reduction with mean (range) ipsilateral and contralateral PG shrinkage of 19.6% (0.9%-58.4%) and 17.7% (4.4%-56.3%), respectively. Midtreatment volume change was highly correlated with mean PG dose (r = -0.318, P < 1e-6). Incidence of grade ≥1 and grade ≥2 xerostomia was 65% and 16%, respectively. For grade ≥1 xerostomia prediction, the delta-imaging model had an AUC of 0.719 (95% confidence interval [CI], 0.603-0.830), compared with 0.709 (95% CI, 0.603-0.815) for the dose/clinical model. For grade ≥2 xerostomia prediction, the dose/clinical model had an AUC of 0.692 (95% CI, 0.615-0.770), and the addition of contralateral PG changes modestly improved predictive performance, with an AUC of 0.776 (0.643-0.912). CONCLUSIONS: The rate of CBCT-measured PG image feature changes improves prediction over dose alone for chronic xerostomia prediction. Analysis of CBCT images acquired for treatment positioning may provide an inexpensive monitoring system to support toxicity-reducing adaptive radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Rosen BS, Hawkins PG, Polan DF, et al. Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 30003997. doi:10.1016/j.ijrobp.2018.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。